Uma resposta superior para pacientes com alta demanda física
HYMOVIS®
TODO PRODUTO FIDIA APRESENTA SÓLIDA INFORMAÇÃO
MÉDICO CIENTÍFICA
FIDIA: COMPROMISSO COM A CIÊNCIA - BIBLIOGRAFIA
1) Finelli I, et al. A new viscosupplement based on partially hydrophobic hyaluronic acid: A comparative study. Biorheology 48 (2011)263–275. ; Hymovis IFU. – 2) M. Pavan, D. Galesso, C. Secchieri, C. Guarise International Journal of Biological Macromolecules 2016; 84:221-6 – 3) Schiavinato, Clinical Biomechanicals, 2012 – 4) Henrotin Y. et al., BMC Musculoskeletal Disorders 2019 – 5) Mainil-Varlet cartilagem 2013 – 6) Smith J. Rheumatology 2008; Smith J. Inflammation 2013 – 7) R.M. Irwin – Osteoarthritis and Cartilage 28 (2020) 492e501 – 8) Bonnevie E.D. et al., PLoS One 2019 -9) Gomis – Osteoarthritis and Cartilage (2009) 17:798 – 10) Zorzi C. et al. A new hydrogel for the conservative treatment of meniscal lesions: a randomized controlled study., Joints 2015 – 11) Berton A. et al., J. Clin. Med. 2020 – 12) Priano F, Early Efficacy of Intra-Articular HYADD®4 (Hymovis®) Injections for Symptomatic Knee Osteoarthritis, Joints 2017. – 13) F. BENAZZO, European Review for Medical and Pharmacological Sciences, 2016 – 14) Bernetti A. et al, Front Pharmacol 2021 – 15) Perticarini L, et al. Eur Rev Med Pharmacol Sci 2021
Frictional characterization of injectable hyaluronic acids is more predictive of clinical outcomes
than traditional rheological or viscoelastic characterization Bonnevie E.D. et al., PLoS One 2019.
Hyaluronan derivative Hymovis® increases cartilage volume and type II collagen turnover in
osteoarhritic knee: data from MOKHA study Henrotin Y. et al., BMC Musculoskeletal Disorders 2019.
A new hydrogel for the conservative treatment of meniscal lesions: a randomized controlled study Zorzi C. et al., Joints 2015.
Quantitative Evaluation of Meniscal Healing Process of Degenerative Meniscus Lesions Treated with
Hyaluronic Acid: A Clinical and MRI Study Berton A. et al., J. Clin. Med. 2020.
Hymovis MO.RE. in the treatment of knee and ankle chondropathy in elite athletes: preliminary results of the CHAMPS (Cohort study about HYADD®4-G Administration for Pain relief on Soccer players) prospective clinical study Perticarini L, et al. Eur Rev Med Pharmacol Sci 2021.
Intra-articular injections of HYADD®4-G in male professional soccer players with traumatic or
degenerative knee chondropathy. A pilot, prospective study Tamburrino P. et al., The Journal of Sports Medicine and Physical Fitness 2016.
Intra-articular Hymovis injection for managing Hip OA in active sportsmen.
A 24-month observational retrospective clinical investigation Rando et al. Journal of Clinical Orthopaedics and Trauma 2021.
Evaluation of the efficacy of intra-articular injective treatment with reticular hyaluronic acid
(MO.RE. Technology) in amateur athletes with over-use gonarthrosis Bernetti A. et al., Medicina dello Sport 2020.
A multi-centre, open label, long-term follow-up study to evaluate the benefits of a new
viscoelastic hydrogel (Hymovis®) in the treatment of knee osteoarthritis Benazzo F. et al., European Review for Medical and Pharmacological Sciences 2016.
Early Efficacy of Intra-Articular HYADD®4 (Hymovis®) Injections for Symptomatic Knee Osteoarthritis Priano F., Joints 2017.
New Viscoelastic Hydrogel Hymovis® ONE = MO.RE. Single Intra-articular Injection for the Treatment of Knee Osteoarthritis in Sportsmen: Safety and Efficacy Study Results
Bernetti A. et al, Front Pharmacol 2021.
Intra-articular glenohumeral injections of HYADD®4-G for the treatment of painful shoulder
osteoarthritis: a prospective multicenter, open-label trial Porcellini G. et al., Joints 2015.
Retrospective study on intra-articular injections with Hymovis® in haemophilic patients with
ankle arthropathy Ruosi C. et al., J Orthopaed Traumatol 2013.
Líder Mundial em Pesquisa e Desenvolvimento de Produtos à Base de Ácido Hialurônico.
